Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

OSMAC strategy and LC-MS profiling reveal metabolic diversity and bioactivities of Xylaria thienhirunae SWUF17-44.1

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61389030%3A_____%2F26%3A00647285" target="_blank" >RIV/61389030:_____/26:00647285 - isvavai.cz</a>

  • Výsledek na webu

    <a href="https://doi.org/10.1186/s13213-025-01838-2" target="_blank" >https://doi.org/10.1186/s13213-025-01838-2</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1186/s13213-025-01838-2" target="_blank" >10.1186/s13213-025-01838-2</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    OSMAC strategy and LC-MS profiling reveal metabolic diversity and bioactivities of Xylaria thienhirunae SWUF17-44.1

  • Popis výsledku v původním jazyce

    Background Xylariaceous fungi represent a promising source of secondary metabolites with diverse biological functions. However, their metabolic capacity often remains underestimated under conventional cultivation. The One Strain-Many Compounds (OSMAC) strategy enhances metabolite diversity by altering culture conditions. This study investigated the metabolic potential and bioactivities of Xylaria thienhirunae SWUF17-44.1 using the OSMAC approach. Methods The strain was cultured under four conditions: Czapek yeast extract agar (CYA), Modified Norkrans's C (MNC), potato dextrose broth (PDB), and soluble malt yeast extract agar (SMYA). Extracts were evaluated for antimicrobial activity against bacteria and fungi, antioxidant capacity by DPPH radical scavenging and total phenolic content (TPC), and anti-inflammatory activity via nitric oxide inhibition. Metabolite profiling was performed by thin-layer chromatography and liquid chromatography-mass spectrometry (LC-MS). Results Culture media markedly influenced growth, metabolite yield, and bioactivity. Crude extracts displayed broad-spectrum antimicrobial properties, with stronger activity against Gram-positive bacteria. Antioxidant activity was higher in PDB, whereas TPC was higher in the nutrient-deficient media (CYA and SMYA).This indicates that compounds contributing to TPC do not necessarily drive antioxidant activity. The anti-inflammatory activity was highest in SMYA extracts. LC-MS analysis revealed common and unique metabolites across media, including alkaloids, aminoglycosides, fatty acid derivatives, and phenolics. Identified compounds included p-acetamidophenol, di-homo gamma-linolenoyl-EA, kolanone, and netilmicin. Several unassigned peaks indicated the presence of potentially novel metabolites. Conclusion The OSMAC strategy successfully enhanced the metabolic diversity of X. thienhirunae SWUF17-44.1, leading to extracts with antimicrobial, antioxidant, and anti-inflammatory properties. These findings highlight the strain as a promising source of bioactive compounds and underscore the utility of OSMAC in fungal natural product discovery.

  • Název v anglickém jazyce

    OSMAC strategy and LC-MS profiling reveal metabolic diversity and bioactivities of Xylaria thienhirunae SWUF17-44.1

  • Popis výsledku anglicky

    Background Xylariaceous fungi represent a promising source of secondary metabolites with diverse biological functions. However, their metabolic capacity often remains underestimated under conventional cultivation. The One Strain-Many Compounds (OSMAC) strategy enhances metabolite diversity by altering culture conditions. This study investigated the metabolic potential and bioactivities of Xylaria thienhirunae SWUF17-44.1 using the OSMAC approach. Methods The strain was cultured under four conditions: Czapek yeast extract agar (CYA), Modified Norkrans's C (MNC), potato dextrose broth (PDB), and soluble malt yeast extract agar (SMYA). Extracts were evaluated for antimicrobial activity against bacteria and fungi, antioxidant capacity by DPPH radical scavenging and total phenolic content (TPC), and anti-inflammatory activity via nitric oxide inhibition. Metabolite profiling was performed by thin-layer chromatography and liquid chromatography-mass spectrometry (LC-MS). Results Culture media markedly influenced growth, metabolite yield, and bioactivity. Crude extracts displayed broad-spectrum antimicrobial properties, with stronger activity against Gram-positive bacteria. Antioxidant activity was higher in PDB, whereas TPC was higher in the nutrient-deficient media (CYA and SMYA).This indicates that compounds contributing to TPC do not necessarily drive antioxidant activity. The anti-inflammatory activity was highest in SMYA extracts. LC-MS analysis revealed common and unique metabolites across media, including alkaloids, aminoglycosides, fatty acid derivatives, and phenolics. Identified compounds included p-acetamidophenol, di-homo gamma-linolenoyl-EA, kolanone, and netilmicin. Several unassigned peaks indicated the presence of potentially novel metabolites. Conclusion The OSMAC strategy successfully enhanced the metabolic diversity of X. thienhirunae SWUF17-44.1, leading to extracts with antimicrobial, antioxidant, and anti-inflammatory properties. These findings highlight the strain as a promising source of bioactive compounds and underscore the utility of OSMAC in fungal natural product discovery.

Klasifikace

  • Druh

    J<sub>imp</sub> - Článek v periodiku v databázi Web of Science

  • CEP obor

  • OECD FORD obor

    10606 - Microbiology

Návaznosti výsledku

  • Projekt

    <a href="/cs/project/GA23-05389S" target="_blank" >GA23-05389S: Nové CB2 a BChE modulátory proti Parkinsonově chorobě a souvisejícím patologiím</a><br>

  • Návaznosti

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Ostatní

  • Rok uplatnění

    2026

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    Annals of Microbiology

  • ISSN

    1590-4261

  • e-ISSN

    1869-2044

  • Svazek periodika

    76

  • Číslo periodika v rámci svazku

    1

  • Stát vydavatele periodika

    GB - Spojené království Velké Británie a Severního Irska

  • Počet stran výsledku

    15

  • Strana od-do

    9

  • Kód UT WoS článku

    001674400300001

  • EID výsledku v databázi Scopus